The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis

David Araújo, Michal Shteinberg, Stefano Aliberti, Pieter C. Goeminne, Adam T. Hill, Thomas C. Fardon, Dusanka Obradovic, Glenda Stone, Marion Trautmann, Angela Davis, Katerina Dimakou, Eva Polverino, Anthony De Soyza, Melissa J. McDonnell, James D. Chalmers

Source: Eur Respir J, 51 (2) 1701953; 10.1183/13993003.01953-2017
Journal Issue: February
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
David Araújo, Michal Shteinberg, Stefano Aliberti, Pieter C. Goeminne, Adam T. Hill, Thomas C. Fardon, Dusanka Obradovic, Glenda Stone, Marion Trautmann, Angela Davis, Katerina Dimakou, Eva Polverino, Anthony De Soyza, Melissa J. McDonnell, James D. Chalmers. The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis. Eur Respir J, 51 (2) 1701953; 10.1183/13993003.01953-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predicting the outcome of respiratory Pseudomonas aeruginosa infection in vivo
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017

The clinical impact of Pseudomonas aeruginosa eradication in bronchiectasis in a Dutch referral centre
Source: Eur Respir J, 53 (4) 1802081; 10.1183/13993003.02081-2018
Year: 2019



The clinical impact of pseudomonas aeruginosa eradication in bronchiectasis in a Dutch center of expertise
Source: International Congress 2018 – Bronchiectasis: phenotypes, endotypes and new therapies
Year: 2018



Pseudomonas aeruginosa as an independent predictor of decreased lung function in bronchiectasis
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019

Does a single Pseudomonas aeruginosa isolation predict COPD mortality?
Source: Eur Respir J 2014; 44: 794-797
Year: 2014


Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD.
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020




Risk factors and outcomes of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa: a clinical case-control study
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017

The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis
Source: Eur Respir J 2006; 28: 974-979
Year: 2006



Clinical and microbiological characteristics of Pseudomonas aeruginosa isolates from patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 58s
Year: 2005

Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre
Source: Eur Respir J 2006; 27: 937-943
Year: 2006



Pseudomonas aeruginosa infection and exacerbations in bronchiectasis: more questions than answers
Source: Eur Respir J, 51 (2) 1702497; 10.1183/13993003.02497-2017
Year: 2018



Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients
Source: Eur Respir J, 57 (4) 2000512; 10.1183/13993003.00512-2020
Year: 2021



The clinical evaluation of patients with Pseudomonas aeruginosa detected in respiratory specimens
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012

Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 379s
Year: 2002

Cystic fibrosis infection with clonal strains of Pseudomonas aeruginosa: current knowledge and future management
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=105
Year: 2006

Effect of long term treatment with azithromycin on clinical status and lung function parameters in cystic fibrosis patients colonised by pseudomonas aeruginosa
Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research
Year: 2009

Antibodies against Pseudomonas aeruginosa in patients with cystic fibrosis – clinical application
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018

Does Pseudomonas aeruginosa infection alter sputum viscoelastic properties in bronchiectasis patients?
Source: International Congress 2018 – Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques
Year: 2018

Pseudomonas aeruginosa infections
Source: Respipedia Article
Year: 2018